BIOMARIN PHARMACEUTICAL INC (BMRN)

Healthcare · Pharmaceuticals · Price $64.49
Updated: Aug 29, 2026
Gross Profit (TTM)
$2.6B
Trailing 12 Months
Growth Rate
15.31%
Log-Linear Regression (16Q)
Gross Margin
76.12%
Pricing Power
Revenue
$3.4B
Top Line Sales
Operating Income
$650.0M
After OpEx

📈 Gross Profit History (16 Quarters)

🧮 BMRN Gross Profit Breakdown

Gross Profit = Revenue - Cost of Revenue
Revenue (Total Sales) $3.4B
Less: Cost of Revenue (COGS) $813.6M
Equals: Gross Profit $2.6B

Understanding Gross Profit

Gross Profit is Revenue minus Cost of Revenue (also called Cost of Goods Sold or COGS). It measures how much a company earns from selling its products before subtracting operating expenses. For BMRN, the trailing twelve month gross profit is $2.6B.

Why Gross Profit Matters

Gross margin (Gross Profit / Revenue) is one of the most important indicators of pricing power and competitive advantage. Companies with high and stable gross margins typically have differentiated products, strong brands, or unique capabilities.

BMRN's gross profit growth rate of 15.31% (based on log-linear regression of 16 quarters) indicates strong growth above market averages.

Gross Margin: The Key Metric

BMRN's gross margin of 76.12% shows what percentage of each sales dollar remains after paying direct production costs. Gross margins above 60% are excellent and often indicate software, pharmaceuticals, luxury goods, or other high-value products.

Gross Profit vs Other Profitability Metrics

Operating Income: $650.0M →

Gross Profit minus operating expenses (SG&A, R&D). Shows profitability after all operating costs but before interest and taxes.

Net Income: $499.2M →

The bottom line after all expenses including interest and taxes. The final measure of accounting profit.

Free Cash Flow: $767.1M →

Actual cash generated after capital expenditures. Can differ significantly from gross profit due to working capital and capex.

Revenue: $3.4B →

The top line that gross profit is derived from. Gross margin shows what percentage becomes gross profit.

Summary: BMRN Gross Profit Trend

BIOMARIN PHARMACEUTICAL INC (BMRN) has a gross margin of 76.12%, which Zyberno classifies as excellent for a Healthcare company — above the 60% threshold Zyberno applies to healthcare businesses where IP protection, regulatory moats, and service complexity shape gross margins. Gross profit grew at 15.31% annually — above the 10% threshold Zyberno considers healthy growth above market averages. For complete financial analysis, view the full BMRN stock report on Zyberno.

Frequently Asked Questions

What is BMRN's current gross profit?

BIOMARIN PHARMACEUTICAL INC's trailing twelve month (TTM) gross profit is $2.6B, growing at 15.31% annually — above the 10% threshold Zyberno considers healthy growth above market averages.

Is BMRN's gross profit growing?

BIOMARIN PHARMACEUTICAL INC (BMRN) has a gross margin of 76.12%, which Zyberno classifies as excellent for a Healthcare company — above the 60% threshold Zyberno applies to healthcare businesses where IP protection, regulatory moats, and service complexity shape gross margins. Gross profit grew at 15.31% annually — above the 10% threshold Zyberno considers healthy growth above market averages.

What is BMRN's gross margin?

BIOMARIN PHARMACEUTICAL INC (BMRN) has a gross margin of 76.12%, which Zyberno classifies as excellent for a Healthcare company — above the 60% threshold Zyberno applies to healthcare businesses where IP protection, regulatory moats, and service complexity shape gross margins. Gross profit grew at 15.31% annually — above the 10% threshold Zyberno considers healthy growth above market averages.

What is the difference between gross profit and net income?

Gross profit is Revenue minus Cost of Revenue only. Net income also subtracts operating expenses, interest, and taxes. BMRN's gross profit is $2.6B versus net income of $499.2M.

📊 Valuation Trilogy
Three interconnected metrics built on Owner Earnings
💎
Intrinsic Value
DCF Fair Value
$125.73
🛡️
Margin of Safety
Valuation Gap
48.7%
🎯
Expected Return
Projected Annual
37.1%
Click any metric for full methodology and detailed analysis

📊 Full BMRN Stock Report

See BMRN's intrinsic value, margin of safety, DCF valuation, and complete financial analysis with 250+ metrics.

💵 BMRN Free Cash Flow

Compare to Free Cash Flow which subtracts all capital expenditures, not just maintenance CapEx.

💰 BMRN Owner Earnings

Compare to Buffett's Owner Earnings metric which uses maintenance CapEx instead of total capital expenditures.

📈 BMRN Earnings Per Share

Analyze EPS trends, P/E ratio, earnings yield, and per-share profitability metrics.

🎯 BMRN Earnings Surprise (SUE)

See whether BMRN is beating or missing its own earnings trend — Standardized Unexpected Earnings and post-earnings drift.

📊 BMRN Revenue

Analyze revenue trends, growth rate, P/S ratio, and top-line sales performance.

💰 BMRN Net Income

Analyze the bottom-line profit, P/E ratio, and net profit margin trends.

🔶 BMRN Operating Income

Analyze EBIT, operating margin, and core business profitability before interest and taxes.

💜 BMRN Gross Profit

Analyze gross margin, pricing power, and profitability before operating expenses.

View Full BMRN Report Find More Quality Stocks
Scroll to Top